Greenwich LifeSciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Greenwich LifeSciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q1 2024.
  • Greenwich LifeSciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $4.22M, a 129% increase year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.22M +$2.38M +129% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q1 2023 $1.84M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.